Why I Founded Regeneron: A CEO’s 38-Year Bet on Science

Regeneron Pharmaceuticals (REGN) - A Biotech Powerhouse! 🧬💊

Be Part of the Discovery with Regeneron’s Clinical Trials

Welcome to Science Illuminated | A Regeneron Series

DNA Sequencing Explained: Inside the Regeneron Genetics Center

What is siRNA? Silencing the Signal | Science Illuminated

Regeneron Co-Founder on R&D, Data and Omics

Meant for More: Our Mission

Regeneron drug proves effective in preventing COVID

Regeneron Clinical Trials – Be Part of the Discovery

Inside Regeneron: Science Triumphs Amid Operational Turbulence

Immunogenicity: The Immune Guest List | Science Illuminated

Regeneron Stock Analysis 2026: Q2 Earnings, FDA Approval & Price Target | REGN Biotech Deep Dive

Regeneron's Focus on Genetic Medicines: 2023 Year in Review

The RGC Effect: A Decade of Genomic Discovery Transforming Medicine

Regeneron Pharmaceuticals (REGN) Earnings Call Q3 2026 | Net Sales $400M (+81%)

Regeneron Clinical Trials – Discover What’s Possible

Regeneron Clinical Trials – What’s Your Legacy?

STEM-Fueled: How Regeneron is Fueling the Next Generation of Innovators

Take a Pause for Science | Science Illuminated

Regeneron's LAG-3 Setback & $125M Deal for "Undruggable" Targets | BioSpark Biotech Review

Regeneron (REGN) Securities Class Action Filed - Sept 14, 2026 Lead Plaintiff Deadline - Act Now

Why Regeneron Rejects Big Pharma Mergers To Build A Drug Monopoly | Pharma Warfare Ep.5

REGN Shareholder Meeting: My Take on the 8-K

See Science Differently | Science Illuminated

How Gene Silencing Technology Could Transform Disease Treatment | Spectacular Science

Trump Regeneron Infomercial | The Daily Show

Inside Regeneron’s Scientific Journey: Advancing Genetics & Biology

The Future of CRISPR: Beyond DNA Cutting in Genetic Medicine | The Nucleus